
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP

We’re fighting to eliminate preventable kidney disease, accelerate innovation, and dismantle structural inequities in kidney care. Join our fight.

If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP

If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP

This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/4oN0ojP

Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: bit.ly/3H23xMj

Join us virtually as we highlight real-world implementation data from NKF’s flagship CKDintercept program, a national strategy to improve CKD testing, diagnosis, and management in the primary care setting. RSVP: bit.ly/4niApQz

Today is #C3GAwarenessDay! C3G is a rare kidney disease with a lifelong impact. Explore our resources for understanding, diagnosing, and treating C3G. kidney.org/kidney-topics/com…

Patients with kidney disease deserve more than outdated technology and limited options. Let’s create better treatments and better outcomes. support.kidney.org/campaign/…

We are one community united by a shared belief in the lifesaving power of our collective steps. Will you contribute to our goal by walking with us? KidneyWalk.org #KidneyWalk

Jessika and Joey didn’t let kidney failure stop them from falling in love or planning a wedding at the Kidney Walk. Here’s how their NKF community helped make it happen. kidney.org/news-stories/he-p…

TODAY is Kidney Heroes Giving Day! Today we honor KIDNEY HEROES and the life-changing difference they make for people with kidney disease. From donors and recipients to doctors and family members, anyone can be a kidney hero. Honor your hero: bit.ly/44W83Wq

When Patrick experienced sudden foot pain, he never imagined it would lead to a diagnosis of IgA nephropathy, or IgAN, a serious form of chronic kidney disease. kidney.org/news-stories/10-y…

Currently, there aren’t enough donated kidneys to meet the growing demand. But xenotransplantation could help change that. kidney.org/news-stories/clin…

If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/3H23xMj

Tell your legislator to support programs that work to increase early detection, improve outcomes, address health disparities, and develop innovative treatments for kidney patients. bit.ly/4bP557V

This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/3H23xMj

RESET-SLE™ is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational cell therapy, CABA-201, in patients with active lupus nephritis (LN) or active lupus (SLE) without renal involvement. Learn more about the study at reset-sle-trial.com.